These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7532870)

  • 21. Suppression of immunoglobulin resynthesis after plasmapheresis: efficacy of various immunosuppressive drugs--a study in rats.
    Kozlowski T; Tibell A; Morpurgo E; Sundberg B; Sundin U; Groth C
    Transplant Proc; 1995 Dec; 27(6):3545-6. PubMed ID: 8540094
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors.
    Zeevi A; Yao GZ; Venkataramanan R; Duquesnoy RJ; Todo S; Fung JJ; Starzl TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):781-3. PubMed ID: 7679843
    [No Abstract]   [Full Text] [Related]  

  • 23. New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation.
    Kahan BD
    Ther Immunol; 1994 Jan; 1(1):33-44. PubMed ID: 7584478
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunosuppressive drugs and the induction of transplantation tolerance.
    Thomson AW
    Transpl Immunol; 1994 Dec; 2(4):263-70. PubMed ID: 7535641
    [No Abstract]   [Full Text] [Related]  

  • 25. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
    [No Abstract]   [Full Text] [Related]  

  • 26. Myoblast allotransplantation in mice: degree of success varies depending on the efficacy of various immunosuppressive treatments.
    Vilquin JT; Asselin I; Guérette B; Kinoshita I; Lille S; Roy R; Tremblay JP
    Transplant Proc; 1994 Dec; 26(6):3372-3. PubMed ID: 7998179
    [No Abstract]   [Full Text] [Related]  

  • 27. Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone.
    Oz HS; Hughes WT
    J Infect Dis; 1997 Apr; 175(4):901-4. PubMed ID: 9086147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of immunosuppressive therapy on the rat aortic allograft model.
    Steele DM; Hullett DA; Bechstein WO; Kowalski J; Smith LS; Kennedy E; Allison AC; Sollinger HW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):754-5. PubMed ID: 8438469
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of immunosuppressants on human leukocyte NADPH oxidase.
    Engelbrecht ME; Oosthuizen MM; Myburgh JA
    Ann N Y Acad Sci; 1994 Jun; 723():436-8. PubMed ID: 7518204
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.
    Brazelton TR; Morris RE
    Curr Opin Immunol; 1996 Oct; 8(5):710-20. PubMed ID: 8902398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effects of cyclosporin analogs--A, D, G, IMM-125--with rapamycin and/or brequinar.
    Kahan BD; Chou T; Tejpal N; Wang M; Chee C; Stepkowski S
    Transplant Proc; 1994 Oct; 26(5):3021-4. PubMed ID: 7940951
    [No Abstract]   [Full Text] [Related]  

  • 32. New immunosuppressive agents for organ transplantation.
    Waer M
    Acta Clin Belg; 1997; 52(4):199-203. PubMed ID: 9351290
    [No Abstract]   [Full Text] [Related]  

  • 33. [Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].
    Rondeau E
    Nephrologie; 1992; 13(3):137. PubMed ID: 1379348
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunology in clinical practice. VI. Current immunosuppressive drugs].
    ten Berge RJ; Schellekens PT
    Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2289-92. PubMed ID: 9550813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.
    Bierer BE
    Proc Assoc Am Physicians; 1995 Apr; 107(1):28-40. PubMed ID: 8630742
    [No Abstract]   [Full Text] [Related]  

  • 36. The interaction of immunosuppressive compounds in tandem stimulated peripheral human lymphocytes.
    Weaver JL; Pine PS; Aszalos A
    Immunopharmacol Immunotoxicol; 1994 May; 16(2):179-90. PubMed ID: 7521360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Historical development of brequinar sodium as a new immunosuppressive drug for transplantation.
    Makowka L; Chapman F; Cramer DV
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):2-7. PubMed ID: 8516937
    [No Abstract]   [Full Text] [Related]  

  • 38. In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.
    Morris RE
    Transplant Proc; 1991 Dec; 23(6):2722-4. PubMed ID: 1721257
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunosuppressive drugs after lung transplantation.
    Briffa N; Morris RE
    BMJ; 1998 Mar; 316(7133):719-20. PubMed ID: 9529396
    [No Abstract]   [Full Text] [Related]  

  • 40. Onset of liver regeneration after subtotal resection is inhibited by the use of new immunosuppressive drugs.
    Dahmen U; Gu Y; Shen K; Dirsch O; Li J; Fan L; Broelsch C
    Transplant Proc; 2002 Sep; 34(6):2312-3. PubMed ID: 12270412
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.